foxo4 dri peptide senolytic study FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice FOXO4-DRI: The Senolytic Peptide That

These animals were housed under controlled environmental conditions and had free access to food and water [1]

Research objectives: Fat-loss studies: 500600 mcg daily typical Dose-response studies: multiple dose levels (300, 500, 1000 mcg) Safety studies: start low (300 mcg) and escalate Combination studies: may use lower doses when combining with other compounds Individual factors: Baseline body fat percentage Metabolic rate and activity level Previous peptide experience Concurrent interventions (diet, exercise) Research timeline and goals Reconstitution Protocol Proper reconstitution of AOD9604 is essential for accurate dosing and peptide stability

B.TvrdeicA.et al (2020b)

F., Finnerty, C

Cutting-Edge Technology We use advanced diagnostic tools like 3D body composition and metabolic breath analysis to track your progress